Evidence map›Paper›PMID 7914906›Full record

ArticleThe Journal of experimental medicine1994

Protein tyrosine kinase p56-Lck regulates lymphocyte function-associated 1 adhesion molecule expression, granule exocytosis, and cytolytic effector function in a cloned T cell.

T Torigoe, J A Millan, K W Chan, R Taichman, A A Brian, J C Reed, R ] Tachman R [corrected to Taichman

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

T TorigoeLa Jolla Cancer Research Foundation, Cancer Research Center, California 92037.
J A Millan
K W Chan
R Taichman
A A Brian
J C Reed
R ] Tachman R [corrected to Taichman
National Foundation for Cancer Research · US

Funding

KINASE ENCODING PROTO-ONCOGENES IN IL-2 SIGNAL TRANSDUCTR01CA054957 · NCI · UNIVERSITY OF PENNSYLVANIA · PI REED, JOHN C · 1991 to 1993
–
ACCESSORY MOLECULES--ANTIGEN-SPECIFIC T-CELL ACTIVATIONR01GM048054 · NIGMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI BRIAN, ADRIENNE A · 1992 to 1995
–
NCI NIH HHS CA-54957NIGMS NIH HHS GM-48054
6 · The paper itself

Abstract

Elevated levels of p56-Lck kinase activity were achieved in an interleukin 2 (IL-2)-dependent cloned cytolytic T cell CTLL-2 through gene transfer approaches. CTLL-2-Lck cells remained dependent on IL-2 for growth and survival in culture but exhibited markedly elevated, IL-2-independent cytolytic activity against a variety of tumor targets. This immune cell effector function was similar to the non-major histocompatibility complex-restricted cytolytic activity previously described for lymphokine activated killer (LAK) cells, and involved a cytolytic mechanism that was independent of protein synthesis in either the T cells or the tumor targets. Characterization of CTLL-2-Lck cells revealed markedly elevated levels of both the alpha (CD11a) and beta (CD18) chains of the cell adhesion molecule lymphocyte function-associated 1 (LFA-1) and increased binding of these T cells to a recombinant protein representing the extracellular domain of the LFA-ligand, intercellular adhesion molecule 1 (ICAM-1). Antibodies to CD11a partially abrogated cytolytic killing of tumor target cells by CTLL-2-Lck cells, suggesting that the upregulation in LFA protein levels potentially accounts at least in part for the phenotype of these T cells. Gene transfer-mediated elevations in p56-Lck kinase activity in an IL-3-dependent myeloid cell clone 32D.3 also resulted in increased LFA-1 expression, demonstrating that the findings are not unique to CTLL-2 cells. In addition to upregulation of LFA-1 expression, CTLL-Lck cells also exhibited more efficient exocytosis of cytotoxic granules upon activation with Ca(2+)-ionophore and phorbol ester, relative to control transfected and untransfected CTLL-2 cells. The findings functionally link the Lck kinase to a T cell effector pathway involved in cell-mediated cytotoxicity.

Indexed as

Cytotoxicity, ImmunologicExocytosisCell AdhesionCell Adhesion MoleculesCells, CulturedClone CellsCytoplasmic GranulesGlucuronidaseHumansIntercellular Adhesion Molecule-1Lymphocyte Function-Associated Antigen-1Lymphocyte Specific Protein Tyrosine Kinase p56(lck)Protein-Tyrosine KinasesT-LymphocytesTransfectionCell Adhesion MoleculesGlucuronidaseIntercellular Adhesion Molecule-1Lymphocyte Function-Associated Antigen-1Lymphocyte Specific Protein Tyrosine Kinase p56(lck)Protein-Tyrosine Kinases

Identifiers

PMID7914906
PMCPMC2191636
OpenAlexW1920406192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.